F G A Moore1, C Wolfson. 1. Department of Nurology, McGill University, Montereal, Quebec, Canada. fmoore1@po-box.mcgill.ca
Abstract
OBJECTIVES: To systematically review the published evidence for a relationship between human herpes virus 6 (HHV-6) and multiple sclerosis (MS). MATERIALS AND METHODS: The medical literature was searched using MEDLINE and the Cochrane database. Retrieved studies are presented according to the experimental technique(s) used. The studies are rated for quality using a priori defined criteria. RESULTS: Twenty-eight studies were retrieved. A total of 12 different experimental techniques were used. Four of these techniques provided evidence for a relationship between HHV-6 and MS, but none were able to show a causative relationship. CONCLUSIONS: The available literature provides some support for a relationship between HHV-6 and MS. The limitations of the available studies and directions for future research are discussed.
OBJECTIVES: To systematically review the published evidence for a relationship between human herpes virus 6 (HHV-6) and multiple sclerosis (MS). MATERIALS AND METHODS: The medical literature was searched using MEDLINE and the Cochrane database. Retrieved studies are presented according to the experimental technique(s) used. The studies are rated for quality using a priori defined criteria. RESULTS: Twenty-eight studies were retrieved. A total of 12 different experimental techniques were used. Four of these techniques provided evidence for a relationship between HHV-6 and MS, but none were able to show a causative relationship. CONCLUSIONS: The available literature provides some support for a relationship between HHV-6 and MS. The limitations of the available studies and directions for future research are discussed.
Authors: Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas Journal: Clin Microbiol Rev Date: 2004-01 Impact factor: 26.132
Authors: Elaine O'Loughlin; Charlotte Madore; Hans Lassmann; Oleg Butovsky Journal: Cold Spring Harb Perspect Med Date: 2018-02-01 Impact factor: 6.915